eyeforpharma Philadelphia 2020: Become healthcare's solution

Healthcare is broken in the USA – but Pharma can lead the way to a new sustainable model

As we enter a new decade, and an election year, the pressure has never been higher on the pharmaceutical industry to justify what we add to the cost of healthcare. Price control has become a bipartisan issue and across the wide-range of policy positions that are on the table in Fall 2020, one area is clear: the transition towards value-based care is inevitable.
Join 1200+ of pharma’s top decision-makers at eyeforpharma Philadelphia (April 15-16) – the largest commercial pharma conference in North America – where the industry will come together to define a better way forward.
With an exceptional speaker faculty spanning eight functional tracks - including digital and marketing, sales, access, patient, RWE and data and commercial – the agenda is packed full of real-life case studies and tailored to the attendees’ learning needs. This really is a must-attend for anyone involved in US pharma and we are very excited to be involved on the program.
Speakers include:
·        Ramona Sequeira, President, Takeda U.S.A
·        Sebastian Guth, President, Americas, Bayer
·        Ivan Cheung, CEO & President, Eisai Inc.
·        Rob Scott, Chief Medical Officer, Abbvie
·        Chris Leibman, SVP, Value and Access, Biogen
·        Scott Howell, VP and Head, US Market Access, Pharmaceuticals, Novartis
With 100+ case studies showcased by the leading voices that are driving pharma forward, eyeforpharma is the top destination for making sure your company gets right to the forefront of innovation.
If you would like more information, or a quote for a group rate saving (2 people or more qualify), please get in touch with Lead Event Director, Karla Sharp at ksharp@eyeforpharma.com
comments powered by Disqus